Welcome to our dedicated page for Prestige Consumer Healthcare SEC filings (Ticker: PBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Prestige Consumer Healthcare's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Prestige Consumer Healthcare's regulatory disclosures and financial reporting.
Prestige Consumer Healthcare executive William P’Pool reported equity compensation awards and related tax withholding in common stock. On May 4, 2026, 4,187 shares settled from previously granted performance stock units based on per share growth goals, and 3,675 Restricted Stock Units were awarded at no cost. To cover tax obligations, 1,888 shares were withheld at $55.31 per share. After these transactions, P’Pool directly holds 28,149 common shares, and 100 additional shares are held indirectly in the P’Pool Family Giving Fund.
Prestige Consumer Healthcare Senior VP of Operations Jeffrey Zerillo reported routine equity compensation activity and a small share sale. He received stock awards of 2,857 and 2,450 common shares at no cost, reflecting PSU settlement and RSU grants. To cover tax obligations, 1,243 shares were disposed of, and he later sold 346 shares in an open-market transaction at about $55.32 per share. After these transactions, he directly holds 44,334 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare EVP of Marketing & Sales Adel Mekhail reported equity compensation activity. On May 4, 2026, he acquired 4,014 shares of common stock through settlement of performance stock units that vested based on per share growth goals, and received 3,505 shares of restricted stock.
The company withheld 1,695 shares at $55.31 per share to cover tax obligations, a non‑market disposition. Following these transactions, Mekhail directly owns 26,190 common shares. The restricted stock is scheduled to vest in three equal installments of 1,338 shares on May 4, 2027, May 4, 2028 and May 4, 2029.
Prestige Consumer Healthcare Inc. reported equity compensation changes for Chief Executive Officer Ronald M. Lombardi. He acquired 19,662 shares of common stock on settlement of performance stock units that vested on May 4, 2026 based on per share growth goals, and received a separate grant of 31,468 Restricted Stock Units.
To cover tax obligations, 16,789 shares were disposed of at $55.31 per share through a tax-withholding mechanism rather than an open-market sale. Following these transactions, Lombardi directly holds 358,543 shares of Prestige Consumer Healthcare common stock. The new Restricted Stock Units vest in three equal installments of 6,554 shares in 2027, 2028 and 2029.
PBH insider submitted a Form 144 reporting proposed sales of Common Stock. The notice lists a proposed transaction through Fidelity Brokerage Services and references a Restricted Stock Vesting event dated 05/04/2026. The filing also reports prior dispositions of 1,000 shares on 02/11/2026 and 346 shares on 05/05/2026, with dollar amounts shown for those sales.
Prestige Consumer Healthcare Inc. executive Christine Sacco, the company’s CFO & COO, reported a tax-related share disposition. She had 1,091 shares of common stock withheld at $55.09 per share to cover tax obligations, a non-market transaction. After this withholding, she directly holds 58,344 common shares.
Prestige Consumer Healthcare Inc. insider Jeffrey Zerillo, Senior VP Operations, reported a tax-related share disposition. On May 2, 2026, 432 shares of common stock were withheld at $55.09 per share to cover tax obligations. Following this non-market transaction, he directly holds 40,616 shares.
Prestige Consumer Healthcare Inc. Chief Executive Officer Ronald M. Lombardi reported a routine tax-related share disposition. On May 2, 2026, 2,665 shares of common stock were withheld at $55.09 per share to cover tax obligations, a non‑market transaction. Following this event, Lombardi directly holds 343,864 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare EVP Adel Mekhail reported a compensation-related share withholding. On this Form 4, 542 shares of common stock were disposed of at $55.09 per share as a tax-withholding disposition, meaning shares were delivered to cover tax obligations rather than sold on the open market. Following this transaction, Mekhail directly holds 20,366 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare Inc. officer William P’Pool reported routine share movements involving company common stock. On May 2, 2026, 599 shares were disposed of at $55.09 per share as a tax-withholding disposition to cover obligations, not as an open-market sale. After this transaction, P’Pool held 22,175 shares directly. A separate indirect entry shows 100 shares held in the P’Pool Family Giving Fund via Fidelity Charitable, reflecting a charitable-related position rather than personal trading.